• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five forces analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o 25-hydroxyvitamin D testing – Market size and forecast 2020-2025
o Market opportunity by Product
• Market Segmentation by End-user
o Market segments
o Comparison by End user
o Diagnostic laboratories – Market size and forecast 2020-2025
o Hospitals and physician clinics – Market size and forecast 2020-2025
o Home care settings – Market size and forecast 2020-2025
o Market opportunity by End user
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o Asia – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o bioMérieux SA
o Danaher Corp.
o DiaSorin Spa
o Diazyme Laboratories Inc.
o F. Hoffmann-La Roche Ltd.
o Quest Diagnostics Inc.
o Quidel Corp.
o Siemens Healthineers AG
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Parent market
• 10: Market characteristics
• 11: Offerings of vendors included in the market definition
• 12: Market segments
• 13: Global – Market size and forecast 2020 – 2025 ($ million)
• 14: Global market: Year-over-year growth 2020 – 2025 (%)
• 15: Five forces analysis 2020 & 2025
• 16: Bargaining power of buyers
• 17: Bargaining power of suppliers
• 18: Threat of new entrants
• 19: Threat of substitutes
• 20: Threat of rivalry
• 21: Market condition – Five forces 2020
• 22: Product – Market share 2020-2025 (%)
• 23: Comparison by Product
• 24: 25-hydroxyvitamin D testing – Market size and forecast 2020-2025 ($ million)
• 25: 25-hydroxyvitamin D testing – Year-over-year growth 2020-2025 (%)
• 26: 1,25-dihydroxyvitamin D testing – Market size and forecast 2020-2025 ($ million)
• 27: 1,25-dihydroxyvitamin D testing – Year-over-year growth 2020-2025 (%)
• 28: Market opportunity by Product
• 29: End user – Market share 2020-2025 (%)
• 30: Comparison by End user
• 31: Diagnostic laboratories – Market size and forecast 2020-2025 ($ million)
• 32: Diagnostic laboratories – Year-over-year growth 2020-2025 (%)
• 33: Hospitals and physician clinics – Market size and forecast 2020-2025 ($ million)
• 34: Hospitals and physician clinics – Year-over-year growth 2020-2025 (%)
• 35: Home care settings – Market size and forecast 2020-2025 ($ million)
• 36: Home care settings – Year-over-year growth 2020-2025 (%)
• 37: Market opportunity by End user
• 38: Customer landscape
• 39: Market share by geography 2020-2025 (%)
• 40: Geographic comparison
• 41: North America – Market size and forecast 2020-2025 ($ million)
• 42: North America – Year-over-year growth 2020-2025 (%)
• 43: Europe – Market size and forecast 2020-2025 ($ million)
• 44: Europe – Year-over-year growth 2020-2025 (%)
• 45: Asia – Market size and forecast 2020-2025 ($ million)
• 46: Asia – Year-over-year growth 2020-2025 (%)
• 47: ROW – Market size and forecast 2020-2025 ($ million)
• 48: ROW – Year-over-year growth 2020-2025 (%)
• 49: Key leading countries
• 50: Market opportunity by geography ($ million)
• 51: Impact of drivers and challenges
• 52: Vendor landscape
• 53: Landscape disruption
• 54: Industry risks
• 55: Vendors covered
• 56: Market positioning of vendors
• 57: Abbott Laboratories – Overview
• 58: Abbott Laboratories – Business segments
• 59: Abbott Laboratories – Key offerings
• 60: Abbott Laboratories – Key customers
• 61: Abbott Laboratories – Segment focus
• 62: bioMérieux SA – Overview
• 63: bioMérieux SA – Business segments
• 64: bioMérieux SA – Key offerings
• 65: bioMérieux SA – Key customers
• 66: bioMérieux SA – Segment focus
• 67: Danaher Corp. – Overview
• 68: Danaher Corp. – Business segments
• 69: Danaher Corp. – Key offerings
• 70: Danaher Corp. – Key customers
• 71: Danaher Corp. – Segment focus
• 72: DiaSorin Spa – Overview
• 73: DiaSorin Spa – Business segments
• 74: DiaSorin Spa – Key offerings
• 75: DiaSorin Spa – Key customers
• 76: DiaSorin Spa – Segment focus
• 77: Diazyme Laboratories Inc. – Overview
• 78: Diazyme Laboratories Inc. – Product and service
• 79: Diazyme Laboratories Inc. – Key offerings
• 80: Diazyme Laboratories Inc. – Key customers
• 81: Diazyme Laboratories Inc. – Segment focus
• 82: F. Hoffmann-La Roche Ltd. – Overview
• 83: F. Hoffmann-La Roche Ltd. – Business segments
• 84: F. Hoffmann-La Roche Ltd. – Key offerings
• 85: F. Hoffmann-La Roche Ltd. – Key customers
• 86: F. Hoffmann-La Roche Ltd. – Segment focus
• 87: Quest Diagnostics Inc. – Overview
• 88: Quest Diagnostics Inc. – Business segments
• 89: Quest Diagnostics Inc. – Key offerings
• 90: Quest Diagnostics Inc. – Key customers
• 91: Quest Diagnostics Inc. – Segment focus
• 92: Quidel Corp. – Overview
• 93: Quidel Corp. – Business segments
• 94: Quidel Corp. – Key offerings
• 95: Quidel Corp. – Key customers
• 96: Quidel Corp. – Segment focus
• 97: Siemens Healthineers AG – Overview
• 98: Siemens Healthineers AG – Business segments
• 99: Siemens Healthineers AG – Key offerings
• 100: Siemens Healthineers AG – Key customers
• 101: Siemens Healthineers AG – Segment focus
• 102: Thermo Fisher Scientific Inc. – Overview
• 103: Thermo Fisher Scientific Inc. – Business segments
• 104: Thermo Fisher Scientific Inc. – Key offerings
• 105: Thermo Fisher Scientific Inc. – Key customers
• 106: Thermo Fisher Scientific Inc. – Segment focus
• 107: Currency conversion rates for US$
• 108: Research Methodology
• 109: Validation techniques employed for market sizing
• 110: Information sources
• 111: List of abbreviations
❖ 掲載企業 ❖
Abbott Laboratories, bioMérieux SA, Danaher Corp., DiaSorin Spa, Diazyme Laboratories Inc., F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc., Quidel Corp., Siemens Healthineers AG, Thermo Fisher Scientific Inc.
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer